MRZ
0.275
570.7%
AR1
0.047
-70.6%
BUY
0.003
50%
MAY
0.007
-53.3%
VBC
0.15
30.4%
DTI
0.021
-30%
CR9
0.005
25%
VAR
0.005
-28.6%
LEG
0.01
25%
FRX
0.018
-28%
RKB
0.005
25%
MSG
0.008
-27.3%
TYX
0.005
25%
AYM
0.003
-25%
CPN
0.12
23.7%
NAE
0.003
-25%
SRR
0.049
22.5%
RDS
0.003
-25%
AN1
0.006
20%
T3D
0.075
-25%
MML
0.024
20%
ANG
0.215
-23.2%
GR8
0.23
17.9%
FAU
0.007
-22.2%
IMI
0.014
16.7%
SCN
0.021
-22.2%
MPR
0.007
16.7%
XPN
0.014
-22.2%
NHE
0.035
16.7%
TRI
0.022
-21.4%
BDG
0.058
16%
GLA
0.015
-21.1%
JGH
0.03
15.4%
AUR
0.023
-20.7%
AEV
0.008
14.3%
ALY
0.008
-20%
VBS
0.165
13.8%
CAV
0.004
-20%
SPQ
0.009
12.5%
FIN
0.008
-20%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH